A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.
Clinical trial NCT05896163 · TERMINATED
Trial details
- NCT number
- NCT05896163
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-30
- Primary completion
- 2026-04-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.